nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—Hypertension worsened—Octreotide—thymus cancer	0.0569	0.0685	CcSEcCtD
Telmisartan—Diabetic—Octreotide—thymus cancer	0.0372	0.0448	CcSEcCtD
Telmisartan—Haemorrhoids—Octreotide—thymus cancer	0.0211	0.0254	CcSEcCtD
Telmisartan—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.018	0.0217	CcSEcCtD
Telmisartan—Influenza-like symptoms—Octreotide—thymus cancer	0.0174	0.0209	CcSEcCtD
Telmisartan—Otitis media—Octreotide—thymus cancer	0.016	0.0192	CcSEcCtD
Telmisartan—Arthropathy—Octreotide—thymus cancer	0.0137	0.0165	CcSEcCtD
Telmisartan—AGTR1—neck—thymus cancer	0.0125	0.0733	CbGeAlD
Telmisartan—Vaginal inflammation—Octreotide—thymus cancer	0.0124	0.015	CcSEcCtD
Telmisartan—Hyperkalaemia—Octreotide—thymus cancer	0.0122	0.0147	CcSEcCtD
Telmisartan—Cystitis noninfective—Octreotide—thymus cancer	0.0121	0.0146	CcSEcCtD
Telmisartan—Influenza like illness—Octreotide—thymus cancer	0.0121	0.0145	CcSEcCtD
Telmisartan—Cystitis—Octreotide—thymus cancer	0.012	0.0144	CcSEcCtD
Telmisartan—Vaginal infection—Octreotide—thymus cancer	0.0117	0.0141	CcSEcCtD
Telmisartan—Cramps of lower extremities—Octreotide—thymus cancer	0.0114	0.0137	CcSEcCtD
Telmisartan—SLCO1B3—pituitary gland—thymus cancer	0.0113	0.0667	CbGeAlD
Telmisartan—Bladder pain—Octreotide—thymus cancer	0.0112	0.0135	CcSEcCtD
Telmisartan—Diabetes mellitus—Octreotide—thymus cancer	0.0104	0.0125	CcSEcCtD
Telmisartan—PPARG—neck—thymus cancer	0.0102	0.0603	CbGeAlD
Telmisartan—Gastroenteritis—Octreotide—thymus cancer	0.0102	0.0123	CcSEcCtD
Telmisartan—Cardiac failure congestive—Octreotide—thymus cancer	0.00994	0.012	CcSEcCtD
Telmisartan—Visual disturbance—Octreotide—thymus cancer	0.00951	0.0115	CcSEcCtD
Telmisartan—Arthritis—Octreotide—thymus cancer	0.00928	0.0112	CcSEcCtD
Telmisartan—AGTR1—hematopoietic system—thymus cancer	0.00927	0.0546	CbGeAlD
Telmisartan—Hypoglycaemia—Octreotide—thymus cancer	0.00924	0.0111	CcSEcCtD
Telmisartan—Pain in extremity—Octreotide—thymus cancer	0.00902	0.0109	CcSEcCtD
Telmisartan—Osteoarthritis—Octreotide—thymus cancer	0.00902	0.0109	CcSEcCtD
Telmisartan—SLCO1B3—lung—thymus cancer	0.00888	0.0523	CbGeAlD
Telmisartan—AGTR1—epithelium—thymus cancer	0.00848	0.0499	CbGeAlD
Telmisartan—Dry skin—Octreotide—thymus cancer	0.00826	0.00996	CcSEcCtD
Telmisartan—Cramp muscle—Octreotide—thymus cancer	0.00812	0.00978	CcSEcCtD
Telmisartan—Gastritis—Octreotide—thymus cancer	0.00798	0.00961	CcSEcCtD
Telmisartan—Muscular weakness—Octreotide—thymus cancer	0.00795	0.00958	CcSEcCtD
Telmisartan—Abdominal distension—Octreotide—thymus cancer	0.00784	0.00945	CcSEcCtD
Telmisartan—Asthma—Octreotide—thymus cancer	0.00779	0.00939	CcSEcCtD
Telmisartan—Bronchospasm—Octreotide—thymus cancer	0.00766	0.00923	CcSEcCtD
Telmisartan—PPARG—hematopoietic system—thymus cancer	0.00763	0.0449	CbGeAlD
Telmisartan—Sweating increased—Octreotide—thymus cancer	0.00759	0.00914	CcSEcCtD
Telmisartan—Bronchitis—Octreotide—thymus cancer	0.00749	0.00903	CcSEcCtD
Telmisartan—Abdominal discomfort—Octreotide—thymus cancer	0.00747	0.009	CcSEcCtD
Telmisartan—Dysuria—Octreotide—thymus cancer	0.00729	0.00878	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Octreotide—thymus cancer	0.00724	0.00872	CcSEcCtD
Telmisartan—Pollakiuria—Octreotide—thymus cancer	0.0072	0.00867	CcSEcCtD
Telmisartan—AGTR1—cardiac atrium—thymus cancer	0.00704	0.0414	CbGeAlD
Telmisartan—Pneumonia—Octreotide—thymus cancer	0.00699	0.00842	CcSEcCtD
Telmisartan—PPARG—epithelium—thymus cancer	0.00697	0.041	CbGeAlD
Telmisartan—Depression—Octreotide—thymus cancer	0.00693	0.00835	CcSEcCtD
Telmisartan—AGTR1—pituitary gland—thymus cancer	0.00688	0.0405	CbGeAlD
Telmisartan—Neuropathy peripheral—Octreotide—thymus cancer	0.00681	0.0082	CcSEcCtD
Telmisartan—Urinary tract infection—Octreotide—thymus cancer	0.00675	0.00814	CcSEcCtD
Telmisartan—Conjunctivitis—Octreotide—thymus cancer	0.00675	0.00814	CcSEcCtD
Telmisartan—Haematuria—Octreotide—thymus cancer	0.00662	0.00798	CcSEcCtD
Telmisartan—Hepatobiliary disease—Octreotide—thymus cancer	0.00657	0.00792	CcSEcCtD
Telmisartan—Epistaxis—Octreotide—thymus cancer	0.00655	0.00789	CcSEcCtD
Telmisartan—AGTR1—lymphoid tissue—thymus cancer	0.00653	0.0384	CbGeAlD
Telmisartan—Sinusitis—Octreotide—thymus cancer	0.00652	0.00785	CcSEcCtD
Telmisartan—Bradycardia—Octreotide—thymus cancer	0.00635	0.00765	CcSEcCtD
Telmisartan—Rhinitis—Octreotide—thymus cancer	0.00625	0.00753	CcSEcCtD
Telmisartan—Hypoaesthesia—Octreotide—thymus cancer	0.00621	0.00748	CcSEcCtD
Telmisartan—Pharyngitis—Octreotide—thymus cancer	0.00619	0.00746	CcSEcCtD
Telmisartan—Oedema peripheral—Octreotide—thymus cancer	0.00614	0.0074	CcSEcCtD
Telmisartan—Visual impairment—Octreotide—thymus cancer	0.00601	0.00724	CcSEcCtD
Telmisartan—AGTR1—thyroid gland—thymus cancer	0.00593	0.0349	CbGeAlD
Telmisartan—Tinnitus—Octreotide—thymus cancer	0.00582	0.00701	CcSEcCtD
Telmisartan—Flushing—Octreotide—thymus cancer	0.00579	0.00697	CcSEcCtD
Telmisartan—Cardiac disorder—Octreotide—thymus cancer	0.00579	0.00697	CcSEcCtD
Telmisartan—CYP2C19—hematopoietic system—thymus cancer	0.00576	0.0339	CbGeAlD
Telmisartan—Immune system disorder—Octreotide—thymus cancer	0.00563	0.00679	CcSEcCtD
Telmisartan—Arrhythmia—Octreotide—thymus cancer	0.00557	0.00671	CcSEcCtD
Telmisartan—Mental disorder—Octreotide—thymus cancer	0.00546	0.00658	CcSEcCtD
Telmisartan—Malnutrition—Octreotide—thymus cancer	0.00543	0.00654	CcSEcCtD
Telmisartan—Erythema—Octreotide—thymus cancer	0.00543	0.00654	CcSEcCtD
Telmisartan—AGTR1—lung—thymus cancer	0.00539	0.0317	CbGeAlD
Telmisartan—PPARG—lymphoid tissue—thymus cancer	0.00537	0.0316	CbGeAlD
Telmisartan—Flatulence—Octreotide—thymus cancer	0.00535	0.00645	CcSEcCtD
Telmisartan—Tension—Octreotide—thymus cancer	0.00533	0.00642	CcSEcCtD
Telmisartan—Nervousness—Octreotide—thymus cancer	0.00527	0.00635	CcSEcCtD
Telmisartan—Back pain—Octreotide—thymus cancer	0.00525	0.00633	CcSEcCtD
Telmisartan—Muscle spasms—Octreotide—thymus cancer	0.00522	0.00629	CcSEcCtD
Telmisartan—Ill-defined disorder—Octreotide—thymus cancer	0.00504	0.00607	CcSEcCtD
Telmisartan—Anaemia—Octreotide—thymus cancer	0.00502	0.00605	CcSEcCtD
Telmisartan—Malaise—Octreotide—thymus cancer	0.0049	0.0059	CcSEcCtD
Telmisartan—PPARG—bone marrow—thymus cancer	0.00489	0.0288	CbGeAlD
Telmisartan—Vertigo—Octreotide—thymus cancer	0.00488	0.00588	CcSEcCtD
Telmisartan—PPARG—thyroid gland—thymus cancer	0.00488	0.0287	CbGeAlD
Telmisartan—Syncope—Octreotide—thymus cancer	0.00487	0.00587	CcSEcCtD
Telmisartan—Palpitations—Octreotide—thymus cancer	0.0048	0.00578	CcSEcCtD
Telmisartan—Loss of consciousness—Octreotide—thymus cancer	0.00477	0.00575	CcSEcCtD
Telmisartan—Cough—Octreotide—thymus cancer	0.00474	0.00571	CcSEcCtD
Telmisartan—Hypertension—Octreotide—thymus cancer	0.00469	0.00565	CcSEcCtD
Telmisartan—Arthralgia—Octreotide—thymus cancer	0.00462	0.00557	CcSEcCtD
Telmisartan—Myalgia—Octreotide—thymus cancer	0.00462	0.00557	CcSEcCtD
Telmisartan—Chest pain—Octreotide—thymus cancer	0.00462	0.00557	CcSEcCtD
Telmisartan—Anxiety—Octreotide—thymus cancer	0.00461	0.00555	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00459	0.00553	CcSEcCtD
Telmisartan—Discomfort—Octreotide—thymus cancer	0.00457	0.0055	CcSEcCtD
Telmisartan—Dry mouth—Octreotide—thymus cancer	0.00452	0.00545	CcSEcCtD
Telmisartan—Anaphylactic shock—Octreotide—thymus cancer	0.00443	0.00534	CcSEcCtD
Telmisartan—Oedema—Octreotide—thymus cancer	0.00443	0.00534	CcSEcCtD
Telmisartan—PPARG—lung—thymus cancer	0.00443	0.0261	CbGeAlD
Telmisartan—Infection—Octreotide—thymus cancer	0.0044	0.0053	CcSEcCtD
Telmisartan—Shock—Octreotide—thymus cancer	0.00436	0.00525	CcSEcCtD
Telmisartan—Nervous system disorder—Octreotide—thymus cancer	0.00435	0.00524	CcSEcCtD
Telmisartan—Thrombocytopenia—Octreotide—thymus cancer	0.00434	0.00523	CcSEcCtD
Telmisartan—Tachycardia—Octreotide—thymus cancer	0.00432	0.00521	CcSEcCtD
Telmisartan—Skin disorder—Octreotide—thymus cancer	0.0043	0.00519	CcSEcCtD
Telmisartan—Hyperhidrosis—Octreotide—thymus cancer	0.00428	0.00516	CcSEcCtD
Telmisartan—Anorexia—Octreotide—thymus cancer	0.00422	0.00509	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00404	0.00486	CcSEcCtD
Telmisartan—Insomnia—Octreotide—thymus cancer	0.00401	0.00483	CcSEcCtD
Telmisartan—Paraesthesia—Octreotide—thymus cancer	0.00398	0.00479	CcSEcCtD
Telmisartan—Dyspnoea—Octreotide—thymus cancer	0.00395	0.00476	CcSEcCtD
Telmisartan—Somnolence—Octreotide—thymus cancer	0.00394	0.00475	CcSEcCtD
Telmisartan—Dyspepsia—Octreotide—thymus cancer	0.0039	0.0047	CcSEcCtD
Telmisartan—Decreased appetite—Octreotide—thymus cancer	0.00385	0.00464	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Octreotide—thymus cancer	0.00383	0.00461	CcSEcCtD
Telmisartan—Fatigue—Octreotide—thymus cancer	0.00382	0.0046	CcSEcCtD
Telmisartan—Pain—Octreotide—thymus cancer	0.00379	0.00456	CcSEcCtD
Telmisartan—Constipation—Octreotide—thymus cancer	0.00379	0.00456	CcSEcCtD
Telmisartan—AGTR1—lymph node—thymus cancer	0.00368	0.0217	CbGeAlD
Telmisartan—Feeling abnormal—Octreotide—thymus cancer	0.00365	0.0044	CcSEcCtD
Telmisartan—ABCG2—pituitary gland—thymus cancer	0.00363	0.0213	CbGeAlD
Telmisartan—Gastrointestinal pain—Octreotide—thymus cancer	0.00362	0.00437	CcSEcCtD
Telmisartan—Urticaria—Octreotide—thymus cancer	0.00352	0.00424	CcSEcCtD
Telmisartan—Abdominal pain—Octreotide—thymus cancer	0.0035	0.00422	CcSEcCtD
Telmisartan—Body temperature increased—Octreotide—thymus cancer	0.0035	0.00422	CcSEcCtD
Telmisartan—Hypersensitivity—Octreotide—thymus cancer	0.00326	0.00393	CcSEcCtD
Telmisartan—Asthenia—Octreotide—thymus cancer	0.00318	0.00383	CcSEcCtD
Telmisartan—Pruritus—Octreotide—thymus cancer	0.00313	0.00378	CcSEcCtD
Telmisartan—ABCG2—bone marrow—thymus cancer	0.00313	0.0184	CbGeAlD
Telmisartan—ABCG2—thyroid gland—thymus cancer	0.00313	0.0184	CbGeAlD
Telmisartan—Diarrhoea—Octreotide—thymus cancer	0.00303	0.00365	CcSEcCtD
Telmisartan—PPARG—lymph node—thymus cancer	0.00303	0.0178	CbGeAlD
Telmisartan—Dizziness—Octreotide—thymus cancer	0.00293	0.00353	CcSEcCtD
Telmisartan—ABCG2—lung—thymus cancer	0.00284	0.0167	CbGeAlD
Telmisartan—Vomiting—Octreotide—thymus cancer	0.00282	0.00339	CcSEcCtD
Telmisartan—Rash—Octreotide—thymus cancer	0.00279	0.00337	CcSEcCtD
Telmisartan—Dermatitis—Octreotide—thymus cancer	0.00279	0.00336	CcSEcCtD
Telmisartan—Headache—Octreotide—thymus cancer	0.00278	0.00334	CcSEcCtD
Telmisartan—ABCC2—lymph node—thymus cancer	0.00266	0.0157	CbGeAlD
Telmisartan—Nausea—Octreotide—thymus cancer	0.00263	0.00317	CcSEcCtD
Telmisartan—ABCB1—hematopoietic system—thymus cancer	0.00241	0.0142	CbGeAlD
Telmisartan—ABCB1—epithelium—thymus cancer	0.0022	0.013	CbGeAlD
Telmisartan—ABCG2—lymph node—thymus cancer	0.00194	0.0114	CbGeAlD
Telmisartan—ABCB1—pituitary gland—thymus cancer	0.00179	0.0105	CbGeAlD
Telmisartan—ABCB1—lymphoid tissue—thymus cancer	0.0017	0.00999	CbGeAlD
Telmisartan—ABCB1—bone marrow—thymus cancer	0.00155	0.00909	CbGeAlD
Telmisartan—ABCB1—thyroid gland—thymus cancer	0.00154	0.00907	CbGeAlD
Telmisartan—ABCB1—lung—thymus cancer	0.0014	0.00824	CbGeAlD
Telmisartan—ABCB1—lymph node—thymus cancer	0.000958	0.00563	CbGeAlD
